NASDAQ : CYTK
Cytokinetics, Incorporated — Financial statements
Healthcare · Biotechnology · United States
Last price 63.31 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 8.80B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Cytokinetics, Incorporated (CYTK) reported revenue of 67.67M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 67.67M | 88.04M | 18.47M | 7.53M | 7.59M | 70.43M |
| Other Revenue | 87.00M | |||||
| Revenue | 67.67M | 88.04M | 18.47M | 7.53M | 94.59M | 70.43M |
| Cost of Revenue | 405.11M | 416.03M | 339.41M | 330.12M | 240.81M | 159.94M |
| Gross Profit | -337.44M | -327.99M | -320.93M | -322.59M | -146.22M | -89.51M |
| Selling, General & Admin | 370.47M | 284.27M | 215.31M | 173.61M | 177.98M | 96.80M |
| Operating Expenses | 370.47M | 284.27M | 215.31M | 173.61M | 177.98M | 96.80M |
| Operating Income | -707.91M | -612.26M | -536.25M | -496.20M | -324.20M | -186.31M |
| Interest Expense | -124.82M | -103.87M | -86.51M | -57.67M | -51.16M | -29.33M |
| Interest & Investment Income | 46.68M | 48.42M | 51.53M | 27.63M | 11.34M | 331.00K |
| Other Non Operating Income (Expenses) | 13.30M | 4.00M | -18.30M | |||
| EBT Excluding Unusual Items | -772.75M | -663.71M | -589.53M | -526.24M | -364.02M | -215.31M |
| Other Unusual Items | -121.25M | -121.25M | -24.94M | |||
| Pretax Income | -894.00M | -784.96M | -589.53M | -526.24M | -388.95M | -215.31M |
| Net Income | -894.00M | -784.96M | -589.53M | -526.24M | -388.95M | -215.31M |
| Net Income to Common | -894.00M | -784.96M | -589.53M | -526.24M | -388.95M | -215.31M |
| Shares Outstanding (Basic) | 124.47M | 120.10M | 111.98M | 96.52M | 89.83M | 76.89M |
| Shares Outstanding (Diluted) | 124.47M | 120.10M | 111.98M | 96.52M | 89.83M | 76.89M |
| EPS (Basic) | -7.18 | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| EPS (Diluted) | -7.18 | -6.54 | -5.26 | -5.45 | -4.33 | -2.80 |
| Free Cash Flow | -580.72M | -534.82M | -399.80M | -415.75M | -310.85M | -191.39M |
| Free Cash Flow Per Share | -4.67 | -4.45 | -3.57 | -4.31 | -3.46 | -2.49 |
| Gross Margin | -154.59% | -127.09% | ||||
| Operating Margin | -1,046.12% | -695.44% | -2,902.72% | -6,589.71% | -342.75% | -264.54% |
| Profit Margin | -1,321.12% | -891.60% | -3,191.11% | -6,988.63% | -411.21% | -305.72% |
| Free Cash Flow Margin | -858.16% | -607.48% | -2,164.10% | -5,521.23% | -328.64% | -271.76% |
| EBITDA | -695.36M | -602.13M | -526.72M | -484.31M | -318.39M | -184.04M |
| EBITDA Margin | -261.31% | |||||
| D&A For EBITDA | 12.55M | 10.12M | 9.53M | 11.89M | 5.81M | 2.28M |
| EBIT | -707.91M | -612.26M | -536.25M | -496.20M | -324.20M | -186.31M |
| EBIT Margin | -264.54% | |||||
| Revenue as Reported | 67.67M | 88.04M | 18.47M | 7.53M | 94.59M | 70.43M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 255.27M | 122.52M | 94.86M | 113.02M | 65.58M | 112.67M |
| Short-Term Investments | 910.41M | 759.70M | 981.16M | 501.80M | 717.00M | 358.97M |
| Cash & Short-Term Investments | 1.17B | 882.22M | 1.08B | 614.82M | 782.58M | 471.64M |
| Accounts Receivable | 24.43M | 17.76M | 16.65M | 1.28M | 147.00K | 56.82M |
| Receivables | 24.43M | 17.76M | 16.65M | 1.28M | 147.00K | 56.82M |
| Prepaid Expenses | 17.99M | 16.99M | 15.28M | 11.94M | 12.46M | 7.21M |
| Total Current Assets | 1.21B | 916.98M | 1.11B | 628.05M | 795.19M | 535.67M |
| Property, Plant & Equipment | 151.81M | 155.17M | 140.97M | 147.74M | 163.19M | 146.41M |
| Long-Term Investments | 543.32M | 335.05M | 145.06M | 40.53M | 46.71M | 152.05M |
| Other Long-Term Assets | 20.93M | 17.34M | 7.71M | 8.00M | 9.69M | 7.19M |
| Total Assets | 1.92B | 1.42B | 1.40B | 824.32M | 1.01B | 841.32M |
| Accounts Payable | 20.51M | 22.34M | 20.37M | 21.51M | 25.61M | 21.09M |
| Accrued Expenses | 76.86M | 83.28M | 55.32M | 42.64M | 44.10M | 34.37M |
| Short-Term Debt | 30.70M | 31.10M | 11.30M | |||
| Current Portion of Long-Term Debt | 27.36M | 41.18M | 11.52M | 10.08M | 958.00K | |
| Current Portion of Leases | 21.04M | 19.11M | 18.98M | 17.89M | 12.83M | 14.86M |
| Current Unearned Revenue | 1.65M | 1.61M | 52.37M | |||
| Other Current Liabilities | 3.30M | 3.83M | 9.81M | 10.56M | 1.12M | 1.54M |
| Total Current Liabilities | 181.43M | 202.45M | 179.67M | 102.68M | 84.62M | 71.86M |
| Long-Term Debt | 1.24B | 1.24B | 768.60M | 607.37M | 609.62M | 142.84M |
| Long-Term Leases | 102.43M | 107.97M | 112.58M | 120.43M | 126.89M | 112.23M |
| Long-Term Unearned Revenue | 558.05M | 520.56M | 462.19M | 379.98M | 300.50M | 266.07M |
| Other Long-Term Liabilities | 13.20M | 13.70M | 14.00M | 186.00K | 1.04M | 4.46M |
| Total Liabilities | 2.10B | 2.08B | 1.54B | 1.21B | 1.12B | 597.46M |
| Common Stock | 138.00K | 123.00K | 118.00K | 102.00K | 94.00K | 84.00K |
| Additional Paid-In Capital | 3.72B | 2.83B | 2.56B | 1.73B | 1.48B | 1.45B |
| Retained Earnings | -3.89B | -3.49B | -2.70B | -2.11B | -1.59B | -1.21B |
| Comprehensive Income & Other | -3.83M | 630.00K | 2.40M | -10.00K | -3.59M | -869.00K |
| Shareholders' Equity | -173.49M | -659.62M | -135.37M | -386.32M | -107.90M | 243.86M |
| Total Liabilities & Equity | 1.92B | 1.42B | 1.40B | 824.32M | 1.01B | 841.32M |
| Total Debt | 1.42B | 1.44B | 922.98M | 755.77M | 750.30M | 269.93M |
| Net Cash (Debt) | -258.77M | -556.62M | 153.04M | -140.95M | 32.28M | 201.71M |
| Net Cash Per Share | -2.08 | -4.63 | 1.37 | -1.46 | 0.36 | 2.62 |
| Filing Date Shares Outstanding | 139.02M | 123.16M | 118.41M | 103.00M | 95.16M | 84.86M |
| Total Common Shares Outstanding | 138.76M | 122.94M | 118.21M | 101.64M | 94.83M | 84.80M |
| Working Capital | 1.03B | 714.52M | 928.27M | 525.37M | 710.57M | 463.81M |
| Book Value Per Share | -1.25 | -5.37 | -1.15 | -3.80 | -1.14 | 2.88 |
| Tangible Book Value | -173.49M | -659.62M | -135.37M | -386.32M | -107.90M | 243.86M |
| Tangible Book Value Per Share | -1.25 | -5.37 | -1.15 | -3.80 | -1.14 | 2.88 |
| Machinery | 35.32M | 30.82M | 28.16M | 28.45M | 27.48M | |
| Construction In Progress | 10.35M | 4.07M | 220.00K | 741.00K | 224.00K | |
| Leasehold Improvements | 80.20M | 66.87M | 66.87M | 65.91M | 60.34M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -894.00M | -784.96M | -589.53M | -526.24M | -388.95M | -215.31M |
| Depreciation & Amortization | 12.55M | 10.12M | 9.53M | 11.89M | 5.81M | 2.28M |
| Loss (Gain) From Sale of Assets | 45.00K | |||||
| Asset Writedown & Restructuring Costs | 2.84M | |||||
| Loss (Gain) From Sale of Investments | -130.00K | -25.00K | -19.00K | 35.00K | 107.00K | |
| Stock-Based Compensation | 127.31M | 112.29M | 97.84M | 72.06M | 47.85M | 26.83M |
| Other Operating Activities | 203.60M | 188.19M | 50.58M | 24.83M | 60.37M | 32.38M |
| Change in Accounts Receivable | -16.02M | -1.11M | -15.37M | -1.14M | 56.67M | -47.40M |
| Change in Accounts Payable | 7.84M | 2.66M | -4.48M | -3.48M | 4.52M | 1.05M |
| Change in Unearned Revenue | 309.00K | -50.76M | 52.37M | -87.00M | ||
| Change in Other Net Operating Assets | 8.92M | 13.58M | 3.14M | 7.71M | 1.10M | 54.80M |
| Operating Cash Flow | -555.45M | -510.01M | -395.89M | -414.33M | -299.52M | -142.52M |
| Capital Expenditures | -25.26M | -24.81M | -3.91M | -1.42M | -11.34M | -48.87M |
| Investment in Securities | -478.42M | 41.47M | -549.19M | 240.67M | -250.80M | -98.91M |
| Investing Cash Flow | -503.68M | 16.67M | -553.10M | 239.25M | -262.13M | -147.78M |
| Long-Term Debt Issued | 729.46M | 523.59M | ||||
| Long-Term Debt Repaid | -413.51M | -9.62M | -858.00K | -188.93M | ||
| Net Debt Issued (Repaid) | 314.99M | 315.95M | -9.62M | -858.00K | 334.66M | |
| Issuance of Common Stock | 831.08M | 35.98M | 759.86M | 182.69M | 17.54M | 324.85M |
| Repurchase of Common Stock | -4.27M | -2.47M | -19.63M | -10.52M | -9.60M | -4.87M |
| Other Financing Activities | 100.00M | 175.00M | 200.00M | 50.00M | 173.56M | |
| Financing Cash Flow | 1.24B | 524.46M | 930.61M | 221.32M | 516.17M | 319.98M |
| Foreign Exchange Rate Adjustments | -841.00K | -715.00K | 209.00K | -20.00K | ||
| Net Cash Flow | 181.83M | 30.40M | -18.17M | 46.22M | -45.48M | 29.68M |
| Free Cash Flow | -580.72M | -534.82M | -399.80M | -415.75M | -310.85M | -191.39M |
| Free Cash Flow Margin | -858.16% | -607.48% | -2,164.10% | -5,521.23% | -328.64% | -271.76% |
| Free Cash Flow Per Share | -4.67 | -4.45 | -3.57 | -4.31 | -3.46 | -2.49 |
| Levered Free Cash Flow | -397.41M | -379.62M | -241.29M | -260.37M | -127.01M | -179.83M |
| Unlevered Free Cash Flow | -319.39M | -314.70M | -187.22M | -224.33M | -95.04M | -161.50M |
| Cash Interest Paid | 24.86M | 22.91M | 25.97M | 10.29M | 15.16M | 9.18M |
| Change in Working Capital | -4.77M | -35.63M | 35.66M | 3.09M | -24.70M | 8.46M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 8.76B | 7.77B | 5.55B | 8.19B | 4.34B | 3.82B |
| Enterprise Value | 9.02B | 8.16B | 5.45B | 8.40B | 4.21B | 3.61B |
| Last Close Price | 62.99 | 63.54 | 47.04 | 83.49 | 45.82 | 45.58 |
| PS Ratio | 129.41 | 88.24 | 300.50 | 1,087.18 | 45.84 | 54.29 |
| PB Ratio | -11.78 | -41.01 | -21.19 | -40.19 | 15.68 | |
| P/TBV Ratio | 15.68 | |||||
| EV/Sales Ratio | 133.23 | 92.65 | 294.90 | 1,115.03 | 44.50 | 51.29 |
| Debt / Equity Ratio | -8.21 | -2.18 | -6.82 | -1.96 | -6.95 | 1.11 |
| Net Debt / Equity Ratio | -1.49 | -0.84 | 1.13 | -0.36 | 0.30 | -0.83 |
| Net Debt / EBITDA Ratio | -0.37 | -0.92 | 0.29 | -0.29 | 0.10 | 1.10 |
| Net Debt / FCF Ratio | -0.45 | -1.04 | 0.38 | -0.34 | 0.10 | 1.05 |
| Asset Turnover | 0.04 | 0.06 | 0.02 | 0.01 | 0.10 | 0.10 |
| Quick Ratio | 6.56 | 4.45 | 6.08 | 6.00 | 9.25 | 7.35 |
| Current Ratio | 6.66 | 4.53 | 6.17 | 6.12 | 9.40 | 7.45 |
| Return on Equity (ROE) | -572.15% | -120.54% | ||||
| Return on Assets (ROA) | -28.09% | -27.08% | -30.11% | -33.73% | -21.83% | -16.94% |
| Return on Capital Employed (ROCE) | -40.60% | -50.10% | -43.90% | -68.80% | -34.90% | -24.20% |
| Earnings Yield | -11.40% | -10.10% | -10.62% | -6.43% | -8.97% | -5.63% |
| FCF Yield | -6.63% | -6.88% | -7.20% | -5.08% | -7.17% | -5.01% |
| Buyback Yield / Dilution | -5.07% | -7.26% | -16.01% | -7.46% | -16.83% | -19.16% |